In this follow-up study, which comprised one hundred fifty-nine 9-year-old children born to mothers with GDM, we found no statistically significant differences in cognitive or neuropsychological outcomes between the offspring of mothers who were treated with either metformin or insulin. This evidence concerns the gene INS and gestational diabetes.